Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation. [electronic resource]
Producer: 20171218Description: 15-8 p. digitalISSN:- 1872-8332
- Adenocarcinoma -- metabolism
- Adenocarcinoma of Lung
- Anaplastic Lymphoma Kinase
- Brain -- drug effects
- Brain Neoplasms -- drug therapy
- Carbazoles -- adverse effects
- Crizotinib
- Disease Progression
- Humans
- Lung Neoplasms -- metabolism
- Male
- Middle Aged
- Necrosis -- chemically induced
- Piperidines -- adverse effects
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Radiation Injuries -- chemically induced
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.